Advertisement
Review Article| Volume 20, ISSUE 4, P679-695, October 2004

Ovarian hyperstimulation syndrome

  • Jaime F. Avecillas
    Affiliations
    Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Search for articles by this author
  • Tommaso Falcone
    Affiliations
    Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Search for articles by this author
  • Alejandro C. Arroliga
    Correspondence
    Corresponding author. Section of Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue (G-62), Cleveland, OH 44195
    Affiliations
    Section of Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA

    Fellowship Program, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Search for articles by this author
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Whelan III, J.G.
        • Vlahos N.F.
        The ovarian hyperstimulation syndrome.
        Fertil Steril. 2000; 73: 883-896
        • Smits G.
        • Olatunbosun O.
        • Delbaere A.
        • Pierson R.
        • Vassart G.
        • Costagliola S.
        Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor.
        N Engl J Med. 2003; 349: 760-766
        • Shanbhag S.
        • Bhattacharya S.
        Current management of ovarian hyperstimulation syndrome.
        Hosp Med. 2002; 63: 528-532
        • Navot D.
        Severe ovarian hyperstimulation syndrome.
        in: Gardner D.K. Textbook of assisted reproductive techniques: laboratory and clinical perspectives. 1st edition. Martin Dunitz, London2001: 645-654
        • Forman R.G.
        • Frydman R.
        • Egan D.
        • Ross C.
        • Barlow D.H.
        Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention.
        Fertil Steril. 1990; 53: 502-509
        • Fawzy M.
        • Harrison R.F.
        • Walshe J.
        Ovarian hyperstimulation syndrome: diagnosis, prevention and management.
        Ir Med J. 1998; 91: 86-87
        • Balasch J.
        • Fabregues F.
        • Arroyo V.
        • Jimenez W.
        • Creus M.
        • Vanrell J.A.
        Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach.
        Acta Obstet Gynecol Scand. 1996; 75: 662-667
        • Kaiser U.B.
        The pathogenesis of the ovarian hyperstimulation syndrome.
        N Engl J Med. 2003; 349: 729-732
        • Vasseur C.
        • Rodien P.
        • Beau I.
        • Desroches A.
        • Gerard C.
        • de poncheville L.
        • et al.
        A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome.
        N Engl J Med. 2003; 349: 753-759
        • Brinsden P.R.
        • Wada I.
        • Tan S.L.
        • Balen A.
        • Jacobs H.S.
        Diagnosis, prevention and management of ovarian hyperstimulation syndrome.
        Br J Obstet Gynaecol. 1995; 102: 767-772
        • Delvigne A.
        • Demoulin A.
        • Smitz J.
        • Donnez J.
        • Koninckx P.
        • Dhont M.
        • et al.
        The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features.
        Hum Reprod. 1993; 8: 1353-1360
        • Delvigne A.
        • Rozenberg S.
        Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.
        Hum Reprod Update. 2002; 8: 559-577
        • Enskog A.
        • Henriksson M.
        • Unander M.
        • Nilsson L.
        • Brannstron M.
        Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization.
        Fertil Steril. 1999; 71: 808-814
        • Navot D.
        • Relou A.
        • Birkenfeld A.
        • Rabinowitz R.
        • Brzezinski A.
        • Margalioth E.J.
        Risk factors and prognostic variables in the ovarian hyperstimulation syndrome.
        Am J Obstet Gynecol. 1988; 159: 210-215
        • Lewis C.G.
        • Warnes G.M.
        • Wang X.
        • Matthews C.D.
        Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women.
        Fertil Steril. 1990; 53: 1097-1099
        • Falcone T.
        • Finegood D.T.
        • Fantus I.G.
        • Morris D.
        Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
        J Clin Endocrinol Metab. 1990; 71: 1653-1657
        • MacDougall M.J.
        • Tan S.L.
        • Balen A.
        • Jacobs H.S.
        A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.
        Hum Reprod. 1993; 8: 233-237
        • Smitz J.
        • Camus M.
        • Devroey P.
        • Erard P.
        • Wisanto A.
        • Van Steirteghem A.C.
        Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization.
        Hum Reprod. 1990; 5: 933-937
        • Rizk B.
        • Smitz J.
        Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures.
        Hum Reprod. 1992; 7: 320-327
        • van Wely M.
        • Westergaard L.G.
        • Bossuyt P.M.
        • van der Veen F.
        Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis.
        Fertil Steril. 2003; 80: 1086-1093
        • Felberbaum R.E.
        • Diedrich K.
        Gonadotrophin-releasing hormone antagonists: will they replace the agonists?.
        Reprod Biomed Online. 2003; 6: 43-53
        • The Practice Committee of the American Society for Reproductive Medicine
        Ovarian hyperstimulation syndrome.
        Fertil Steril. 2003; 80: 1309-1314
        • Rabau E.
        • David A.
        • Serr D.M.
        • Mashiach S.
        • Lunenfeld B.
        Human menopausal gonadotropins for anovulation and sterility.
        Am J Obstet Gynecol. 1967; 98: 92-98
        • Navot D.
        • Bergh P.A.
        • Laufer N.
        Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.
        Fertil Steril. 1992; 58: 249-261
        • Mathur R.S.
        • Akande A.V.
        • Keay S.D.
        • Hunt L.P.
        • Jenkins J.M.
        Distinction between early and late ovarian hyperstimulation syndrome.
        Fertil Steril. 2000; 73: 901-907
        • Semba S.
        • Moriya T.
        • Youssef E.M.
        • Sasano H.
        An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion.
        Pathol Int. 2000; 50: 549-552
        • Schenker J.G.
        • Weinstein D.
        Ovarian hyperstimulation syndrome: a current survey.
        Fertil Steril. 1978; 30: 255-268
        • Shigematsu T.
        • Kubota E.
        • Aman M.
        Adult respiratory distress syndrome as a manifestation of ovarian hyperstimulation syndrome.
        Int J Gynaecol Obstet. 2000; 69: 169-170
        • Rouzi A.A.
        Life threatening ovarian hyperstimulation syndrome.
        Int J Gynaecol Obstet. 2000; 68: 269-270
        • Fabregues F.
        • Balasch J.
        • Gines P.
        • Manau D.
        • Jimenez W.
        • Arroyo V.
        • et al.
        Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome.
        Am J Gastroenterol. 1999; 94: 994-999
        • Abramov Y.
        • Naparstek Y.
        • Elchalal U.
        • Lewin A.
        • Schechter E.
        • Schenker J.G.
        Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome.
        Fertil Steril. 1999; 71: 102-105
        • Takamizawa S.
        • Shibahara H.
        • Taneichi A.
        • Obara H.
        • Fujiwara H.
        • Ogawa S.
        • et al.
        Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt.
        American Journal of Reproductive Immunology. 2002; 47: 25-30
        • Abramov Y.
        • Elchalal U.
        • Schenker J.G.
        Febrile morbidity in severe and critical ovarian hyperstimulation syndrome: a multicentre study.
        Hum Reprod. 1998; 13: 3128-3131
        • Levin M.F.
        • Kaplan B.R.
        • Hutton L.C.
        Thoracic manifestations of ovarian hyperstimulation syndrome.
        Can Assoc Radiol J. 1995; 46: 23-26
        • Daniel Y.
        • Yaron Y.
        • Oren M.
        • Peyser M.R.
        • Lessing J.B.
        Ovarian hyperstimulation syndrome manifests as acute unilateral hydrothorax.
        Hum Reprod. 1995; 10: 1684-1685
        • Papanicolaou N.
        • Tzortzakakis H.
        • Giannakopoulos K.
        • Hatzidaki E.
        • Lydataki N.
        • Giannakopoulou C.
        Ovarian hyperstimulation syndrome manifests only as hydrothorax.
        Acta Obstet Gynecol Scand. 1998; 77: 941-943
        • Zosmer A.
        • Katz Z.
        • Lancet M.
        • Konichezky S.
        • Schwartz-Shoham Z.
        Adult respiratory distress syndrome complicating ovarian hyperstimulation syndrome.
        Fertil Steril. 1987; 47: 524-526
        • Padilla S.L.
        • Zamaria S.
        • Baramki T.A.
        • Garcia J.E.
        Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise.
        Fertil Steril. 1990; 53: 365-367
        • Cordani S.
        • Bancalari L.
        • Maggiani R.
        • La Sala G.B.
        • Fiasella F.
        • Canessa P.A.
        Massive unilateral hydrothorax as the only clinical manifestation of ovarian hyperstimulation syndrome.
        Monaldi Arch Chest Dis. 2002; 57: 314-317
        • Thomas F.
        • Kalfon P.
        • Niculescu M.
        Acute respiratory failure, lactic acidosis, and shock associated with a compressive isolated right pleural effusion following ovarian hyperstimulation syndrome.
        Am J Med. 2003; 114: 165-166
        • Tavmergen E.
        • Ozcakir H.T.
        • Levi R.
        • Adakan S.
        • Ulukus M.
        • Terek M.C.
        Bilateral jugular venous thromboembolism and pulmonary emboli in a patient with severe ovarian hyperstimulation syndrome.
        J Obstet Gynaecol Res. 2001; 27: 217-220
        • Stewart J.A.
        • Hamilton P.J.
        • Murdoch A.P.
        Thromboembolic disease associated with ovarian stimulation and assisted conception techniques.
        Hum Reprod. 1997; 12: 2167-2173
        • Heinig J.
        • Behre H.M.
        • Klockenbusch W.
        Occlusion of the ulnar artery in a patient with severe ovarian hyperstimulation syndrome.
        Eur J Obstet Gynecol Reprod Biol. 2001; 96: 126-127
        • Turkistani I.M.
        • Ghourab S.A.
        • Al-Sheikh O.H.
        • Abu el-asrar A.M.
        Central retinal artery occlusion associated with severe ovarian hyperstimulation syndrome.
        Eur J Ophthalmol. 2001; 11: 313-315
        • Koo E.J.
        • Rha J.H.
        • Lee B.I.
        • Kim M.O.
        • Ha C.K.
        A case of cerebral infarct in combined antiphospholipid antibody and ovarian hyperstimulation syndrome.
        J Korean Med Sci. 2002; 17: 574-576
        • Kodama H.
        • Fukuda J.
        • Karube H.
        • Matsui T.
        • Shimizu Y.
        • Tanaka T.
        Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism.
        Fertil Steril. 1995; 64: 1207-1209
        • Kim I.Y.
        • Lee B.H.
        Ovarian hyperstimulation syndrome: US and CT appearances.
        Clin Imaging. 1997; 21: 284-286
        • Merrer J.
        • De Jonghe B.
        • Golliot F.
        • Lefrant J.Y.
        • Raffy B.
        • Barre E.
        • et al.
        Complications of femoral and subclavian venous catheterization in critically ill patients.
        JAMA. 2001; 286: 700-707
        • Timsit J.F.
        • Farkas J.C.
        • Boyer J.M.
        • Martin J.B.
        • Misset B.
        • Renaud B.
        • et al.
        Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis.
        Chest. 1998; 114: 207-213
        • Borenstein R.
        • Elhalah U.
        • Lunenfeld B.
        • Schwartz Z.S.
        Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach.
        Fertil Steril. 1989; 51: 791-795
        • Brower R.G.
        • Matthay M.A.
        • Morris A.
        • Schoenfeld D.
        • Thompson B.T.
        • Wheeler A.
        The acute respiratory distress syndrome network: ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
        N Engl J Med. 2000; 342: 1301-1308
        • Ware L.B.
        • Matthay M.A.
        The acute respiratory distress syndrome.
        N Engl J Med. 2000; 342: 1334-1349
        • Abuzeid M.I.
        • Nassar Z.
        • Massaad Z.
        • Weiss M.
        • Ashraf M.
        • Fakih M.
        Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome.
        Hum Reprod. 2003; 18: 370-373
        • Ogi M.
        • Yokoyama H.
        • Tomosugi N.
        • Hisada Y.
        • Ohta S.
        • Takaeda M.
        • et al.
        Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome.
        Am J Kidney Dis. 1994; 24: 427-436
        • Ferraretti A.P.
        • Gianaroli L.
        • Diotallevi L.
        • Festi C.
        • Trounson A.
        Dopamine treatment for severe ovarian hyperstimulation syndrome.
        Hum Reprod. 1992; 7: 180-183
        • Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group
        Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial.
        Lancet. 2000; 356: 2139-2143
        • Pride S.M.
        • Yuen B.H.
        • Moon Y.S.
        Clinical, endocrinologic, and intraovarian prostaglandin F responses to H-1 receptor blockade in the ovarian hyperstimulation syndrome: studies in the rabbit model.
        Am J Obstet Gynecol. 1984; 148: 670-674
        • Pride S.M.
        • Yuen B.H.
        • Moon Y.S.
        • Leung P.C.
        Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit.
        Am J Obstet Gynecol. 1986; 154: 1155-1160
        • Gergely R.Z.
        • Paldi E.
        • Erlik Y.
        • Makler A.
        Treatment of ovarian hyperstimulation syndrome by antihistamine.
        Obstet Gynecol. 1976; 47: 83-85
        • Knox G.E.
        • Dowd A.J.
        • Spiesel S.A.
        • Hong R.
        Antihistamine blockade of the ovarian hyperstimulation syndrome: II. possible role of antigen-antibody complexes in the pathogenesis of the syndrome.
        Fertil Steril. 1975; 26: 418-421
        • Knox G.E.
        Antihistamine blockade of the ovarian hyperstimulation syndrome.
        Am J Obstet Gynecol. 1974; 118: 992-994
        • Chew S.
        • Ng S.C.
        Laparoscopic treatment of a twisted hyperstimulated ovary after IVF.
        Singapore Med J. 2001; 42: 228-229